Vistin Pharma ASA: Mandatory notification of trade
Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin Pharma ASA at NOK 23.12 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares, corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated with board member Øystein Stray Spetalen. Attachment 20230530_Notification of trade_Ferncliff i Vistin
Comunicato Precedente
Comunicato Successivo
Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin Pharma ASA at NOK 23.12 per share.
After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares, corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated with board member Øystein Stray Spetalen.
Attachment
- 20230530_Notification of trade_Ferncliff i Vistin
Per maggiori informazioni
Sito Web
https://www.vistin.com/
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
;
